Unichem Lab receives USFDA nod for Pramipexole Dihydrochloride Tablets

22 Dec 2018 Evaluate

Unichem Laboratories has received final ANDA approval for its Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, and 1.5 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Boehringer  Ingelheim  Pharmaceuticals Inc.'s Mirapexe Tablets, 0.125 mg. 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, and 1.5 mg.

Pramipaxole Dihydrochloride Tablets are indicated for the treatment of Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome (RLS).

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.

Unichem Lab Share Price

860.55 -21.05 (-2.39%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.